Risk factors associated with alterations in carotid intima—media thickness in hypertension
- 1 July 1998
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hypertension
- Vol. 16 (7), 949-961
- https://doi.org/10.1097/00004872-199816070-00008
Abstract
The possibility that calcium antagonists exert an anti-atherosclerotic action at least partly independently of the blood-pressure-lowering effect is supported by results of a large number of experimental studies and can now be investigated by quantitative β-mode ultrasound imagining of the carotid artery walls. The European Lacidipine Study on Atherosclerosis (ELSA) is a prospective, randomized, double-blind, multinational trial comparing effects of 4-year treatment based on the long-acting, highly lipophilic calcium antagonist lacidipine with those of treatment based on the β-blocker atenolol on the development of carotid artery wall alterations in patients (aged 45–75 years) with mild-to-moderate hypertension (systolic blood pressure 150–210 mmHg and diastolic blood pressure 95–115 mmHg). While the intervention study is progressing, this article summarizes baseline data obtained from the whole cohort of 2259 patients randomly allocated to treatment. Baseline ultrasound data were obtained from two replicate examinations performed shortly before random allocation to treatment by certified sonographers at 23 referral centres and read at the ultrasound coordinating centre at the Wake Forest University School of Medicine. Intima—media thickness was measured at up to 12 different sites in the carotid artery tree and expressed as the mean of the maxima at these sites (Mmax), the mean of the maxima at four sites in the distal common carotid artery and bifurcation (CBMmax) and the maximum intima—media thickness (Tmax). Baseline demographic and clinical measurements were performed by investigators in 410 peripheral clinical units and 24 h ambulatory blood pressure monitorings read and validated by members of a centralized unit at the University of Milan. The statistical analysis centre at the Technische Universität Mächen received and analysed all baseline data, by calculating means ± SD, medians and ranges and performing correlation (Spearman correlation coefficients) and multiple regression analyses. Prevalence of carotid artery wall alterations among the hypertensive patients randomly allocated to treatment in the ELSA was very high: 82% had Tmax > 1.3 mm (‘plaques’ according to protocol) and 17% had Tmax > 1.0 and Conclusions Analysis of baseline data from the ELSA has shown that there is an extremely marked prevalence of carotid artery wall alterations among mild-to-moderate, middle-aged hypertensive patients. In addition to age, systolic blood pressure and pulse pressure, particularly if they are accurately measured by ambulatory monitoring, play a major role, somewhat greater than those of sex, low-density lipoprotein cholesterol concentration and smoking, in influencing intima—media thickness.This publication has 28 references indexed in Scilit:
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 1997
- Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trialJAMA, 1996
- Trials investigating the anti-atherosclerotic effects of antihypertensive drugsJournal of Hypertension, 1996
- Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA)Journal of Hypertension, 1995
- Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart diseaseBritish Medical Bulletin, 1994
- Measurement of the ultrasonic intima-media complex thickness in normal subjectsJournal of Vascular Surgery, 1993
- Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group.Stroke, 1992
- The Antiatherogenic Effects of Antihypertensive Drugs: Experimental and Clinical EvidenceClinical and Experimental Hypertension. Part A: Theory and Practice, 1992
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextThe Lancet, 1990
- Detection and monitoring of asymptomatic atherosclerosis in clinical trialsAmerican Journal Of Medicine, 1989